β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Blog β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03 | 1.23 | 1.06 | 0.23 | 84.56 | 18.96 | 103.52 | 101.86 | 1.66 | 0.07 | 0.01 | 0.02 | 0.01 | 0.31 | 0.02 | 0.07 | 0.06 | 0.55 | 1.58 | 0.01 | 0 | 0 | 0 | 0 | 5916.38 | 0 | 3 | 4.32 | 3.58 | 19.25 | 13.13 | 1.98 | 292.01 | 200.43 | 1088.23 | 0.27 | 0.02 | 0.69 | 0 | 0 | 3.19 | 2.02 | 0.27 | 0.82 | 0.82 | 0.14 | 11.83 | 11.56 | 7.93 | 7.93 | 1.99 | 0.14 | 0.02 | 3.99 | 0.82 |
2023-03 | 1.21 | 1.04 | 0.2 | 79.23 | 19.74 | 98.96 | 103.71 | -4.75 | 0.07 | 0.01 | 0.02 | 0.01 | 0.31 | 0.02 | 0.07 | 0.07 | 0.55 | 1.43 | 0.01 | 0 | 0.01 | 0 | 0.01 | 1440.35 | 2.19 | 3.04 | 4.61 | 3.52 | 18.49 | 12.52 | 1.97 | 76.9 | 12.58 | 813.54 | 0.25 | 0 | 0.16 | 2.19 | 2.42 | 1.2 | 0.7 | 0.25 | 0.67 | 0.67 | 0.11 | 9.76 | 143.37 | 23.46 | 23.46 | 0.31 | 0.11 | 0.03 | 3 | 0.67 |
2022-03 | 1.2 | 1.04 | 0.24 | 78.86 | 18.92 | 97.77 | 107.83 | -10.06 | 0.07 | 0.01 | 0.02 | 0.01 | 0.32 | 0.02 | 0.06 | 0.07 | 0.51 | 1.26 | 0.01 | 0.02 | 0.06 | 0 | 0.05 | 2851.5 | 2.04 | 3.22 | 4.63 | 3.38 | 19.3 | 12.45 | 1.93 | 291.56 | 201.65 | 1247.46 | 0.3 | 0.02 | 0.69 | 2.04 | 2.04 | 3.24 | 2.21 | 0.3 | 0.8 | 0.8 | 0.13 | 14.38 | 9.99 | 6.91 | 6.91 | 0.63 | 0.13 | 0.02 | 3.5 | 0.8 |
2021-03 | 1.23 | 1.07 | 0.23 | 79.77 | 18.95 | 98.72 | 109.61 | -10.9 | 0.07 | 0.01 | 0.02 | 0.01 | 0.32 | 0.01 | 0.05 | 0.05 | 0.49 | 1.28 | 0.01 | 0.02 | 0.06 | 0.05 | 0.06 | 771.52 | 1.13 | 3.21 | 4.58 | 3.33 | 19.26 | 12.28 | 1.91 | 164.07 | 89.44 | 1150.28 | 0.37 | 0.01 | 0.55 | 1.13 | 98.42 | 2.2 | 1.41 | 0.37 | 0.85 | 0.85 | 0.14 | 18.64 | 23.75 | 12.95 | 12.95 | -0.53 | 0.14 | 0.02 | 4.76 | 0.85 |
2020-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more ratios for MediPal Holdings!
Sign up for free or log in
Have you heard about our short Daily Video Newsletter?
Find out more